New hope for tough lung cancers: trial tests combo after other treatments fail
NCT ID NCT07322341
Summary
This study is for people with advanced non-small cell lung cancer that has spread or come back and has gotten worse despite receiving standard chemotherapy and immunotherapy. It tests whether combining an experimental pill called SX-682 with an existing immunotherapy drug (atezolizumab) can help control the cancer. The goal is to see if this new combination can shrink tumors and slow the disease in patients who have run out of standard options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.